Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma

In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative approach in treating advanced hepatocellular carcinoma (HCC). Despite their success, challenges persist, including concerns about their effectiveness, treatment costs, frequent occurrence of treatment-related adver...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ran Qin, Tianqiang Jin, Feng Xu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-12-01
coleção:	Frontiers in Immunology
Assuntos:	immunotherapy hepatocellular carcinoma biomarker PD-L1 HCC immune checkpoint inhibitor
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1326097/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!